Therapeutic window analysis of the neuroprotective effects of cyclosporine a after traumatic brain injury

Journal of Neurotrauma

Volumn 28, Issue 2, 2011, Pages 311-318

  Sullivan, Patrick G ^a   Sebastian, Andrea H ^a   Hall, Edward D ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

brain injury; cortical contusion; cyclosporine; cyclosporine A; mitochondrial permeability transition; neuroprotection

Indexed keywords

CYCLOSPORIN A;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN TISSUE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; MALE; NEUROPROTECTION; NONHUMAN; OSMOTIC MINIPUMP; PHARMACOLOGICAL PARAMETERS; QUANTITATIVE ANALYSIS; RAT; THERAPEUTIC WINDOW; THERAPEUTIC WINDOW ANALYSIS; TRAUMATIC BRAIN INJURY;

ANIMALS; BRAIN INJURIES; CYCLOSPORINE; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; IMMUNOSUPPRESSIVE AGENTS; MALE; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 79951707504     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2010.1646     Document Type: Article

References (68)

1. Alessandri, B., Rice, A.C., Levasseur, J., DeFord, M., Hamm, R.J., and Bullock, M.R. (2002). Cyclosporine A improves brain tissue oxygen consumption and learning/memory performance after lateral fluid percussion injury in rats. J. Neurotrauma 19, 829-841. (Pubitemid 34815501)
2. Ankarcrona, M., Dypbukt, J.M., Bonfoco, E., Zhivotovsky, B., Orrenius, S., Lipton, S.A., and Nicotera, P. (1995). Glutamateinduced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15, 961-973.
3. Baldwin, S.A., Fugaccia, I., Brown, D.R., Brown, L.V., and Scheff, S.W. (1996). Blood-brain barrier breach following cortical contusion in the rat. J. Neurosurg. 85, 476-481. (Pubitemid 26278031)
4. Baldwin, S.A., Gibson, T., Callihan, C.T., Sullivan, P.G., Palmer, E., and Scheff, S.W. (1997). Neuronal cell loss in the CA3 subfield of the hippocampus following cortical contusion utilizing the optical dissector method for cell counting. J. Neurotrauma 14, 385-398. (Pubitemid 27293214)
5. Berden, J.H.M., Hoitsuma, A.J., Merx, J.L., and Keyser, A. (1985). Severe central nervous-system toxicity associated with cyclosporin. Lancet 1, 219-220. (Pubitemid 15151479)
6. Brophy, G.M., Pineda, J., Papa, L., Lewis, S.B., Valadka, A.B., Hannay, H.J., Heaton, S.C., Demery, J.A., Liu, M.C., Tepas, J.J., 3rd, Gabrielli, A., Robicsek, S., Wang, K.K., Robertson, C.S., and Hayes, R.L. (2009). alphaII-Spectrin breakdown product cerebrospinal fluid exposure metrics suggest differences in cellular injury mechanisms after severe traumatic brain injury. J. Neurotrauma 26, 471-479.
7. Budd, S.L., and Nicholls, D.G. (1996). A reevaluation of the role of mitochondria in neuronal Ca2+ homeostasis. J. Neurochem. 66, 403-411.
8. Buki, A., Okonkwo, D.O., and Povlishock, J.T. (1999). Postinjury cyclosporin A administration limits axonal damage and disconnection in traumatic brain injury. J. Neurotrauma 16, 511-521. (Pubitemid 29297905)
9. Choi, D.W., Maulucci-Gedde, M., and Kriegstein, A.R. (1987). Glutamate neurotoxicity in cortical cell culture. J. Neurosci. 7, 357-368. (Pubitemid 17017465)
10. Cook, A.M., Whitlow, J., Hatton, J., and Young, B. (2009). CyclosporineAfor neuroprotection: establishing dosing guidelines for safe and effective use. Expert Opin. Drug Saf. 8, 411-419.
11. Davis, L.M., Pauly, J.R., Readnower, R., Rho, J.M., Sullivan, P.G. (2008). Fasting is neuroprotective following traumatic brain injury. J. Neuro. Res. 86, 1812-1822. (Pubitemid 351859431)
12. de Groen, P.C., Aksamit, A.J., Rakela, J., Forbes, G.S., and Krom, R.A. (1987). Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol. N. Engl. J. Med. 317, 861-866. (Pubitemid 17156729)
13. Deng-Bryant, Y., Singh, I.N., Carrico, K.M., and Hall, E.D. (2008). Neuroprotective effects of tempol, a catalytic scavenger of peroxynitrite- derived free radicals, in a mouse traumatic brain injury model. J. Cereb. Blood Flow Metab. 28, 1114-1126. (Pubitemid 351733341)
14. Deng, Y., Thompson, B.M., Gao, X., and Hall, E.D. (2007). Temporal relationship of peroxynitrite-induced oxidative damage, calpain-mediated cytoskeletal degradation and neurodegeneration after traumatic brain injury. Exp. Neurol. 205, 154-165. (Pubitemid 46621175)
15. Dugan, L.L., Sensi, S.L., Canzoniero, L.M., Handran, S.D., Rothman, S.M., Lin, T.S., Goldberg, M.P., and Choi, D.W. (1995). Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-d-aspartate. J. Neurosci. 15, 6377-6388.
16. Dykens, J.A. (1994). Isolated cerebral and cerebellar mitochondria produce free radicals when exposed to elevated Ca2+ and Na+: implications for neurodegeneration. J. Neurochem. 63, 584-591.
17. Faden, A.I., Demediuk, P., Panter, S.S., and Vink, R. (1989). The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science (New York, NY) 244, 798-800. (Pubitemid 19163864)
18. Famiglio, L., Racusen, L., Fivush, B., Solez, K., and Fisher, R. (1989). Central nervous system toxicity of cyclosporine in a rat model. Transplantation 48, 316-321. (Pubitemid 19210358)
19. Fiskum, G. (2000). Mitochondrial participation in ischemic and traumatic neural cell death. J. Neurotrauma 17, 843-855.
20. Fiskum, G., Murphy, A.N., and Beal, M.F. (1999). Mitochondria in neurodegeneration: acute ischemia and chronic neurodegenerative diseases. J. Cereb. Blood Flow Metab. 19, 351-369. (Pubitemid 30161223)
21. Gilmer, L.K., Roberts, K.N., Joy, K., Sullivan, P.G., and Scheff, S.W. (2009a). Early mitochondrial dysfunction after cortical contusion injury. J. Neurotrauma 26, 1271-1280.
22. Hall, E.D., Bryant, Y.D., Cho, W., and Sullivan, P.G. (2008). Evolution of post-traumatic neurodegeneration after controlled cortical impact traumatic brain injury in mice and rats as assessed by the de Olmos silver and fluorojade staining methods. J. Neurotrauma 25, 235-247. (Pubitemid 351416738)
23. Hall, E.D., Detloff, M.R., Johnson, K., and Kupina, N.C. (2004). Peroxynitrite-mediated protein nitration and lipid peroxidation in a mouse model of traumatic brain injury. J. Neurotrauma 21, 9-20. (Pubitemid 38141798)
24. Hatton, J., Rosbolt, B., Empey, P., Kryscio, R., and Young, B. (2008). Dosing and safety of cyclosporine in patients with severe brain injury. J. Neurosurg. 109, 699-707.
25. Hughes, R.L. (1990). Cyclosporine-related central nervous system toxicity. N. Engl. J. Med. 323, 420-421.
26. Ichas, F., and Mazat, J.P. (1998). From calcium signaling to cell death: two conformations for the mitochondrial permeability transition pore. Switching from low- to high-conductance state. Biochim. Biophys. Acta. 1366, 33-50. (Pubitemid 28467021)
27. Jordan, J., Cena, V., and Prehn, J.H. (2003). Mitochondrial control of neuron death and its role in neurodegenerative disorders. J. Physiol. Biochem. 59, 129-141.
28. Kahan, B.D. (1989). Cyclosporine. N. Engl. J. Med. 321, 1725-1738.
29. Kelley, B.J., Lifshitz, J., and Povlishock, J.T. (2007). Neuroinflammatory responses after experimental diffuse traumatic brain injury. J. Neuropathol. Exp. Neurol. 66, 989-1001. (Pubitemid 350060367)
30. Lifshitz, J., Friberg, H., Neumar, R.W., Raghupathi, R., Welsh, F.A., Janmey, P., Saatman, K.E., Wieloch, T., Grady, M.S., and McIntosh, T.K. (2003). Structural and functional damage sustained by mitochondria after traumatic brain injury in the rat: evidence for differentially sensitive populations in the cortex and hippocampus. J. Cereb. Blood Flow Metab. 23, 219-231. (Pubitemid 36188460)
31. Lifshitz, J., Sullivan, P.G., Hovda, D.A., Wieloch, T., and McIntosh, T.K. (2004). Mitochondrial damage and dysfunction in traumatic brain injury. Mitochondrion 4, 705-713. (Pubitemid 39646816)
32. Maragos, W.F., and Korde, A.S. (2004). Mitochondrial uncoupling as a potential therapeutic target in acute central nervous system injury. J. Neurochem. 91, 257-262. (Pubitemid 39363425)
33. Mazzeo, A.T., Beat, A., Singh, A., and Bullock, M.R. (2009a). The role of mitochondrial transition pore, and its modulation, in traumatic brain injury and delayed neurodegeneration after TBI. Exp. Neurol. 218, 363-370.
34. Mazzeo, A.T., Brophy, G.M., Gilman, C.B., Alves, O.L., Robles, J.R., Hayes, R.L., Povlishock, J.T., and Bullock, M.R. (2009b). Safety and tolerability of cyclosporin a in severe traumatic brain injury patients: results from a prospective randomized trial. J. Neurotrauma 26, 2195-2206.
35. Mbye, L.H., Singh, I.N., Carrico, K.M., Saatman, K.E., and Hall, E.D. (2009). Comparative neuroprotective effects of cyclosporin A and NIM811, a nonimmunosuppressive cyclosporin A analog, following traumatic brain injury. J. Cereb. Blood Flow Metab. 29, 87-97.
36. Mbye, L.H., Singh, I.N., Sullivan, P.G., Springer, J.E., and Hall, E.D. (2008). Attenuation of acute mitochondrial dysfunction after traumatic brain injury in mice by NIM811, a nonimmunosuppressive cyclosporin A analog. Exp. Neurol. 209, 243-253.
37. McGinn, M.J., Kelley, B.J., Akinyi, L., Oli, M.W., Liu, M.C., Hayes, R.L., Wang, K.K., and Povlishock, J.T. (2009). Biochemical, structural, and biomarker evidence for calpainmediated cytoskeletal change after diffuse brain injury uncomplicated by contusion. J. Neuropathol. Exp. Neurol. 68, 241-249.
38. Michel, R.P., and Cruz-Orive, L.M. (1988). Application of the Cavalieri principle and vertical sections method to lung: estimation of volume and pleural surface area. J. Microsc. 150, 117-136.
39. Morganti-Kossmann, M.C., Satgunaseelan, L., Bye, N., and Kossmann, T. (2007). Modulation of immune response by head injury. Injury 38, 1392-1400. (Pubitemid 350192405)
40. Okonkwo, D.O., and Povlishock, J.T. (1999). An intrathecal bolus of cyclosporin A before injury preserves mitochondrial integrity and attenuates axonal disruption in traumatic brain injury. J. Cereb. Blood Flow Metab. 19, 443-451. (Pubitemid 30161232)
41. Pandya, J.D., Pauly, J.R., and Sullivan, P.G. (2009). The optimal dosage and window of opportunity to maintain mitochondrial homeostasis following traumatic brain injury using the uncoupler FCCP. Exp. Neurol. 218, 381-389.
42. Pandya, J.D., Pauly, J.R., Nukala, V.N., Sebastian, A.H., Day, K.M., Korde, A.S., Maragos, W.F., Hall, E.D., and Sullivan, P.G. (2007). Post-injury administration of mitochondrial uncouplers increases tissue sparing and improves behavioral outcome following traumatic brain injury in rodents. J. Neurotrauma 24, 798-811. (Pubitemid 46799272)
43. Patchell, R.A. (1994). Neurologic complications of organ transplant. Ann. Neurol. 36, 688-703.
44. Pike, B.R., Flint, J., Dutta, S., Johnson, E., Wang, K.K., and Hayes, R.L. (2001). Accumulation of non-erythroid alpha IIspectrin and calpain-cleaved alpha II-spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats. J. Neurochem. 78, 1297-1306. (Pubitemid 32899761)
45. Pineda, J.A., Lewis, S.B., Valadka, A.B., Papa, L., Hannay, H.J., Heaton, S.C., Demery, J.A., Liu, M.C., Aikman, J.M., Akle, V., Brophy, G.M., Tepas, J.J., Wang, K.K., Robertson, C.S., and Hayes, R.L. (2007). Clinical significance of alphaII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury. J. Neurotrauma 24, 354-366. (Pubitemid 46492156)
46. Reece, D.E., Frei-Lahr, D.A., Shepherd, J.D., Dorowini-Zis, K., Gascoyne, R.D., Graeb, D.A., Spinelli, J.J., Barnett, M.J., Klingemann, H.G., and Herzig, G.P. (1991). Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin. Bone Marrow Transplant 8, 393-401.
47. Reynolds, I.J., and Hastings, T.G. (1995). Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation. J. Neurosci. 15, 3318-3327.
48. Ringger, N.C., OSteen, B.E., Brabham, J.G., Silver, X., Pineda, J., Wang, K.K., Hayes, R.L., and Papa, L. (2004). A novel marker for traumatic brain injury: CSF alphaII-spectrin breakdown product levels. J. Neurotrauma 21, 1443-1456. (Pubitemid 39435320)
49. Rizzuto, R., Bernardi, P., and Pozzan, T. (2000). Mitochondria as all-round players of the calcium game. J. Physiol. 529, 37-47.
50. Saatman, K.E., Bozyczko-Coyne, D., Marcy, V., Siman, R., and McIntosh, T.K. (1996). Prolonged calpain-mediated spectrin breakdown occurs regionally following experimental brain injury in the rat. J. Neuropathol. Exp. Neurol. 55, 850-860. (Pubitemid 26244130)
51. Saatman, K.E., Creed, J., and Raghupathi, R. (2010). Calpain as a therapeutic target in traumatic brain injury. Neurotherapeutics 7, 31-42.
52. Scheff, S.W., and Sullivan, P.G. (1999). Cyclosporin A significantly ameliorates cortical damage following experimental traumatic brain injury in rodents. J. Neurotrauma 16, 783-792.
53. Scheff, S.W., Baldwin, S.A., Brown, R.W., and Kraemer, P.J. (1997). Morris water maze deficits in rats following traumatic brain injury: lateral controlled cortical impact. J. Neurotrauma 14, 615-627. (Pubitemid 27424265)
54. Singh, I.N., Sullivan, P.G., Deng, Y., Mbye, L.H., and Hall, E.D. (2006a). Time course of post-traumatic mitochondrial oxidative damage and dysfunction in a mouse model of focal traumatic brain injury: implications for neuroprotective therapy. J. Cereb. Blood Flow Metab. 26, 1407-1418. (Pubitemid 44629888)
55. Starkov, A.A., and Fiskum, G. (2003). Regulation of brain mitochondrial H2O2 production by membrane potential and NAD(P)H redox state. J. Neurochem. 86, 1101-1107. (Pubitemid 37022186)
56. Sullivan, P.G., Bruce-Keller, A.J., Rabchevsky, A.G., Christakos, S., Clair, D.K., Mattson, M.P., and Scheff, S.W. (1999a). Exacerbation of damage and altered NF-kappaB activation in mice lacking tumor necrosis factor receptors after traumatic brain injury. J. Neurosci. 19, 6248-6256. (Pubitemid 29347425)
57. Sullivan, P.G. (2005). Interventions with neuroprotective agents: novel targets and opportunities. Epilepsy Behav. 7(Suppl. 3), S12-S17.
58. Sullivan, P.G., Rabchevsky, A.G., Hicks, R.R., Gibson, T.R., Fletcher-Turner, A., and Scheff, S.W. (2000a). Dose-response curve and optimal dosing regimen of cyclosporin A after traumatic brain injury in rats. Neuroscience 101, 289-295.
59. Sullivan, P.G., Rabchevsky, A.G., Waldmeier, P.C., and Springer, J.E. (2005).Mitochondrial permeability transition in CNS trauma: cause or effect of neuronal cell death? J. Neurosci.Res. 79, 231-239. (Pubitemid 40116440)
60. Sullivan, P.G., Rippy, N.A., Dorenbos, K., Concepcion, R.C., Agarwal, A.K., and Rho, J.M. (2004a). The ketogenic diet increases mitochondrial uncoupling protein levels and activity. Ann. Neurol. 55, 576-580. (Pubitemid 38391976)
61. Sullivan, P.G., Springer, J.E., Hall, E.D., and Scheff, S.W. (2004b). Mitochondrial uncoupling as a therapeutic target following neuronal injury. J. Bioenerg. Biomembr. 36, 353-356. (Pubitemid 39619840)
62. Sullivan, P.G., Thompson, M., and Scheff, S.W. (2000b). Continuous infusion of cyclosporin A postinjury significantly ameliorates cortical damage following traumatic brain injury. Exp. Neurol. 161, 631-637. (Pubitemid 30137020)
63. Sullivan, P.G., Thompson, M.B., and Scheff, S.W. (1999b). Cyclosporin A attenuates acute mitochondrial dysfunction following traumatic brain injury. Exp. Neurol. 160, 226-234.
64. Thompson, S.N., Gibson, T.R., Thompson, B.M., Deng, Y., and Hall, E.D. (2006). Relationship of calpain-mediated proteolysis to the expression of axonal and synaptic plasticity markers following traumatic brain injury in mice. Exp. Neurol. 201, 253-265. (Pubitemid 44223479)
65. Vink, R., Nimmo, A.J., and Cernak, I. (2001). An overview of new and novel pharmacotherapies for use in traumatic brain injury. Clin. Exp. Pharmacol Physiol. 28, 919-921. (Pubitemid 33071067)
66. Walker, R.W., and Brochstein, J.A. (1988). Neurologic complications of immunosuppressive agents. Neurologic Clinician 6, 261-278.
67. Wijdicks, E.F.M., Wiesner, R.H., and Krom, R.A.F. (1995). Neurotoxicity in liver transplant recipients with cyclosporine immunosuppression. Neurology 45, 1962-1964.
68. Zipfel, G.J., Babcock, D.J., Lee, J.M., and Choi, D.W. (2000). Neuronal apoptosis after CNS injury: the roles of glutamate and calcium. J. Neurotrauma 17, 857-869.